Literature DB >> 5691983

The X-Y-Z scheme of immunocyte maturation. V. Paralysis of memory cells.

V S Byers, E E Sercarz.   

Abstract

A concentration of 5 mg/ml bovine serum albumin (BSA) prevents the in vitro elicitation of a secondary response in primed rabbit popliteal lymph nodes, if it is left in contact with the node fragments for the first 6 days of culture. No antibody formation can be detected at any time during the culture period in most cases, although occasional fragments are resistant to inhibition. Reducing the exposure time to the first 3 days of culture delays the peak of the antibody response. The inhibition is antigen specific. Reconstruction experiments demonstrate that the inhibition is not due to antigen masking of the antibody. Even shortly after optimal stimulation, the addition of 5 mg/ml BSA to the fragments was not able to prevent a normal antibody response. The implications of these findings are that (a) a high antigen concentration suspends the memory cell in a reversibly paralyzed state, (b) memory cells have a heterogeneous susceptibility to inhibition, (c) once induced, the antibody response cannot be inhibited by antigen overloading, (d) unresponsiveness in a primed animal can be due to either exhaustion of the memory cell population or paralysis of the memory cell.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5691983      PMCID: PMC2138541          DOI: 10.1084/jem.128.4.715

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Elimination of I131 labelled homologous and heterologous serum proteins from blood of various species.

Authors:  W O WEIGLE
Journal:  Proc Soc Exp Biol Med       Date:  1957-02

2.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

Review 3.  Developmental aspects of immunity.

Authors:  J Sterzl; A M Silverstein
Journal:  Adv Immunol       Date:  1967       Impact factor: 3.543

4.  The suppressive effect of supraoptimum doses of antigen on the secondary antibody-forming response of spleen cells cultured in cell-impermeable diffusion chambers.

Authors:  T Makinodan; I Hoppe; T Sado; E E Capalbo; M R Leonard
Journal:  J Immunol       Date:  1965-09       Impact factor: 5.422

5.  The effect of antigen dosage on the response of adoptively transferred cells.

Authors:  O Mäkelä; N A Mitchison
Journal:  Immunology       Date:  1965-06       Impact factor: 7.397

6.  Specific inhibition of antibody production. IV. Standardization of the antigen-elimination test; immunological paralysis of mice previously immunized.

Authors:  D W Dresser
Journal:  Immunology       Date:  1965-09       Impact factor: 7.397

7.  The adsorption of proteins on erythrocytes treated with tannic acid and subsequent hemagglutination by antiprotein sera.

Authors:  S V BOYDEN
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307

8.  High-dose delay of the immune response. Effect of actinomycin D on continuation of the immune response in vitro.

Authors:  J Iványi; M Maler; L Wudl; E Sercarz
Journal:  J Exp Med       Date:  1968-06-01       Impact factor: 14.307

9.  The X-Y-Z scheme of immunocyte maturation. IV. The exhaustion of memory cells.

Authors:  V S Byers; E E Sercarz
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

10.  Quantitative studies of the adoptive immunological memory in mice. II. Linear transmission of cellular memory.

Authors:  F Celada
Journal:  J Exp Med       Date:  1967-02-01       Impact factor: 14.307

View more
  2 in total

1.  Kinetics of the proliferative response to antigen in vitro of rabbit lymph node cells taken at various times after immunization.

Authors:  G W Siskind; G J Thorbecke
Journal:  Immunology       Date:  1971-02       Impact factor: 7.397

2.  Induction and reversal of immune paralysis in vitro.

Authors:  V S Byers; E E Sercarz
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.